Trials / Completed
CompletedNCT02554721
Pharmacodynamic Study of Cilostazol in Healthy Volunteers
Effect of Cilostazol as an add-on Treatment to a Single Antiplatelet Agent (Acetylsalicylic Acid or Clopidogrel) on Platelet Function Testing and Bleeding Time in Healthy Volunteers
- Status
- Completed
- Phase
- Phase 1
- Study type
- Interventional
- Enrollment
- 77 (actual)
- Sponsor
- Otsuka Pharmaceutical Co., Ltd. · Industry
- Sex
- Male
- Age
- 18 Years – 45 Years
- Healthy volunteers
- Accepted
Summary
The primary objective of this study is to investigate the effects of Cilostazol, Acetylsalycylic acid and Clopidogrel alone as well as combinations of Cilostazol/Acetylsalicylic acid and Cilostazol/ Clopidogrel on ex-vivo Platelet Function (PF) testing.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DRUG | Cilostazol | |
| DRUG | Acetylsalicylic acid | |
| DRUG | Clopidogrel |
Timeline
- Start date
- 2015-08-01
- Primary completion
- 2018-03-30
- Completion
- 2018-03-30
- First posted
- 2015-09-18
- Last updated
- 2021-10-13
- Results posted
- 2021-10-13
Locations
1 site across 1 country: Germany
Source: ClinicalTrials.gov record NCT02554721. Inclusion in this directory is not an endorsement.